The rapid increase in communication and transportation between Africa and other continents as well as the erosion of social fabric attended by poverty, ethnic conflicts, and civil wars has led to increased trafficking and consumption of illicit drugs. Cannabis dominates illicit trade and accounts for as much as 40% of global interdiction. Due to escalating seizures in recent years, the illicit trade in heroin and cocaine has become a concern that has quickly spread from West Africa to include Eastern and Southern Africa in the past 10 years. All regions of Africa are characterized by the use of cannabis, reflecting its entrenched status all over Africa. Most alarming though is the use of heroin, which is now being injected frequently and threatens to reverse the gain made in the prevention of HIV/AIDS. The prevalence of HIV infection and other blood borne diseases among injection drug users is five to six times that among the general population, calling for urgent intervention among this group. Programs that aim to reduce the drug trafficking in Africa and needle syringe programs as well as medication assisted treatment (MAT) of heroin dependence while still in their infancy in Africa show promise and need to be scaled up.
Introduction
Concern over drug trafficking and abuse in Africa is a recent phenomenon. A radical change appears to have taken place about 40 years ago when trafficking and abuse crept into the mainstream society, and there has been a dramatic acceleration of these trends during the past 30 years. Concern regarding abuse of drugs such as heroin and cocaine is even more recent, starting about 25 years ago in some countries and escalating to involve more countries in the past 10 years.
There is also consensus of opinion that these changes in drug abuse have been preceded and are accompanied by a gradual shift in trafficking routes as well as gradual and inexorable erosion of traditional social fabric and values. Social disintegration is accelerating under the adverse influences of growing 'poverty, civil war, tribal conflicts, droughts and other natural catastrophes (which leads) to famine and massive displacement of populations, creating a situation in which drug abuse worsens rapidly' (International Narcotics Control Board 1994).
However, with these realities, there is a limited scope of interven tion activities addressing both drug trafficking and drug abuse, highlighting the imperative for comprehensive interventions at all levels in affected countries.
Drug trafficking in Africa
Cannabis production, the domestic market, and intraregional trafficking of cannabis herb dominate the African illicit drug trade (United Nations Office on Drugs and Crime 2011). African countries account for the highest levels of cannabis pro duction in the world and 25% of the world supply (United Nations Office on Drugs and Crime 2007). Cannabis herb that leaves the continent is primarily destined for Europe. In Africa, Morocco dominates the production and trafficking of cannabis resin primarily destined for North Africa and the Middle East (United Nations Office on Drugs and Crime 2007, 2011) .
West Africa was a transit site for heroin trafficking as early as the 1950s, when Lebanese smuggled Near East heroin from Beirut through Kano, Nigeria and Accra, Ghana, to New York City (Akyeampong 2005; Ellis 2009 ). Nigerians and Ghanaian traffick ers joined the global movement of illicit substances during the 1960s when they began exporting cannabis to Europe. During the early 1980s, they added cocaine and heroin to their repertoire (Ellis 2009 Nigerian traffickers set up bases in Benin, Ivory Coast, Liberia, and South Africa during the early 1990s. By the late 1990s, Niger ian crime syndicates dominated the retail market in Moscow and controlled 80% of the North American heroin trade coming from Southeast Asia (Ellis 2009 ). The bulk trade in heroin in large con tainers moved by air and sea, layered on top of the courier system, was first detected in 1993 when Nigerian authorities arrested a Nigerian for transporting 250 kg from a Thailand home.
Of the approximately 470 metric tons of heroin trafficked globally in 2009, the United Nations Office on Drugs and Crime (2011) estimates that 375 tons, or 80%, reached consumers. Authorities believe that during that year traffickers moved 40 45 tons of Afghan heroin into Africa. Twenty five tons were likely trafficked from Pakistan, 5 6 tons from the United Arab Emirates, 5 6 tons from India, and 5 tons from the Islamic Republic of Iran. By 2009, the major transportation hubs in Africa dominated by the West African crime syndicates were Kenya, Tanzania, Nigeria, and South Africa (Harrigan 2009 The Drug Enforcement Administration reports that since 2006, intelligence has been indicating that sub Saharan Africa has become a major transshipment location for methamphetamine precursor chemicals destined for the Americas (Harrigan 2009 ). By at least 2008, the drug itself was being trafficked from Southern Africa to East Asia, and seizures of African origin methamphet amine more than tripled in 2009 (Ellis 2009 ).
Seizure of methaqualone in Africa was at 99% of the global total for the drug in 2009. It is a drug predominantly traded and used in South Africa. Due to dearth in information, it is difficult to estab lish where else the drug is traded. Additionally, while khat is cul tivated in many East African countries, it is not under international control, but some countries have legislation that does not allow its cultivation and trafficking (United Nations Office on Drugs and Crime 2011).
Drug use in Africa
Cannabis, methaqualone, and khat are substances of abuse that are entrenched in the region. Cannabis is the drug that dominates treatment demand, accounting for 64% of the drug using popu lation in Africa (United Nations Office on Drugs and Crime 2011). The estimated numbers of past year users aged 15 64 years in East Africa ranged between 21,630,000 and 59,140,000 for cannabis, from 150,000 to 1,790,000 for opioids, and from 140,000 to 1,300,000 for opiates, with minimal or no use for cocaine, amphetamines, and ecstasy (United Nations Office on Drugs and Crime 2011). In Southern Africa, the estimated numbers of past year users are 3,130,000 7,810,000 for cannabis, 240,000 320,000 for opioids, 210,000 230,000 for opiates, 270,000 730,000 for cocaine, 280,000 780,000 for amphet amines, and 180,000 300,000 for ecstasy (United Nations Office on Drugs and Crime 2011). Although the numbers of amphetamines users in Africa are estimated at 1,180,000 8,150,000; most of these numbers are reflected from Southern Africa (Degenhardt & Hall 2012 ).
The UNODC also estimates the annual cannabis use prevalence rates to be 2.9% for Comoros, 2.1% for Kenya, 9.1% for Madagas car, 3.9% for Mauritius, 2.5% for Somalia, 3.9% for Namibia, 4.3% for South Africa, 9.5% for Zambia, and 6.9% for Zimbabwe (United Nations Office on Drugs and Crime 2011).
With regard to East Africa specifically, the overall prevalence rate of cannabis use in East Africa is estimated to be 1.7 6.5% for the population (United Nations Office on Drugs and Crime 2011). The annual drug use prevalence rate and the estimated number of opiate users for East Africa are 0.1 1.0% for the population aged 15 64 years (United Nations Office on Drugs and Crime 2011). More specifically, for this region, the annual prevalence rate of the use of opiates in Kenya is 0.73%. In Mauritius, it is 1.9% for opiates and the corresponding figures are 0.14% for Rwanda, 0.16% for Somalia, and 0.06% for Uganda. Mauritius has a prevalence rate of 1.04% for non medical use of prescription opiates (United Nations Office on Drugs and Crime 2011). Kenya is the main country in East Africa where cocaine features with a prevalence rate of 1.2% (United Nations Office on Drugs and Crime 2011).
For most countries in Southern Africa, cannabis is the primary drug of abuse (with the population prevalence rate estimated at 3.9 9.8%), and relatively little is known about the use of drugs that have the potential to be injected such as opiates, cocaine, and ATS (United Nations Office on Drugs and Crime 2011; World Health Organization 2011). While the regional prevalence rate for opiate use is estimated to be 0.1% for the population (United Nations Office on Drugs and Crime 2011), the use of ATS seems largely limited to Southern Africa, with amphet amine related problems being reported in South Africa, Zambia, and Zimbabwe (United Nations Office on Drugs and Crime 2011). There are some questions about the validity of the current national estimates for both opiate and ATS use.
An exception to this is South Africa, which arguably has one of the most entrenched drug economies in the region, and illicit drug use is therefore subject to continuous monitoring and inves tigation. Since South Africa's transition to democracy in 1994 and subsequent opening of the country's borders, there has been an influx of and a growing burden of harm associated with illicit drug use. In terms of population level prevalence for illicit drug use, the prevalence rate of opiate use is estimated at 0.1%, cocaine use at 0.3%, ATS at 0.2%, and opiates such as heroin at 0.1% for the population aged 15 49 years (Shisana, Rehle, Simbayi, Parker, Zuma, Bhana, et al. 2005) . In addition, a recent nationally representative survey reported that at least 13% of the general population met DSM IV criteria for a lifetime substance use disorder (Herman, Stein, Seedat, Heeringa, Moomal & Williams 2009) . As this survey only included South African citizens and did not include refugees and other undocu mented persons, it is possible that these estimates under represent the true prevalence of substance use disorders in the country.
However, when regional patterns of illicit drug use are considered, a more disturbing picture emerges. Illicit drug use appears to be concentrated in the large urban centers of the country, with many of the rural provinces still largely unaffected by the use of
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Journal of Social Aspects of HIV/AIDS VOL. 9 NO. 3 SEPTEMBER 2012 illicit drugs that have the potential to be injected (Dada, Plüdde mann, Parry, Bhana, Vawda & Fourie 2011; Herman et al. 2009; Reddy, James, Sewpaul, Koopman, Funani, Sifunda, et al. 2010) . Notably within the large urban centers of the country, the use of illicit drugs that have the potential to be injected (such as cocaine, heroin, and ATS) appears to be on the rise (Dada et al. 2011; ).
Drug-related harm and interventions
Evidence that the use of drugs with the potential to be injected is on the rise in parts of 
Interventions for drug trafficking and use
Overall efforts to address drug problems typically intend to disrupt either the supply side or the demand side of the issue. With regard to supply reduction, international effort at interdic tion of drug trafficking is one of the interventions used to reduce drug trafficking and the supply of drugs. However, the African continent is vast with areas that have poor infrastructure and are thus difficult to man. In addition, the newer trafficking routes often avoid known maritime monitoring routes and focus on trafficking through remote, sparsely populated areas, such as the Sahel; in these areas, law enforcement intelligence and monitoring may be missing (Wyler & Cook 2010) . The failure to interdict drug traffickers is also a result of a lack of man power, technology, and financial resources (Wyler & Cook 2010) . Corruption also serves as a serious threat to the reduction in drug trafficking.
Drug trafficking interventions need to specifically focus on staff to include training maritime, law enforcement, anti corruption, financial, immigration, and customs staff at ports of both entry and exit. In addition, financial support needs to be secured to procure equipment for navigation, communication, and day and night time radar surveillance through the use of vision systems, cars, aircraft, and boats. However, interventions only tar geting the supply side will have limited impact on isolation.
To that end, interventions targeting demand and harm reduction in the form of evidence based treatment, including MAT for opiate dependence and other forms of pharmacotherapy, are vitally important to address drug use more broadly. For over 50 years, MAT has been shown to be a proven strategy which stabilizes clients who are addicted to opiates and restores them to a better quality of life (Dole, Nyswander & Kreek, 1966) . MAT has also been shown to reduce illicit opioid use, injecting use, sharing of injecting equipment, percentage reporting multiple sex part ners, exchanges of sex for drugs or money, and reductions in HIV cases (Gowing, Farrell, Bornemann, Sullivan & Ali, 2011) . Reducing demand for drugs through evidence based treatment and MAT is one of the nine evidence based interventions that form a 'comprehensive package' of interventions for the preven tion, treatment, and care of HIV among people who inject drugs as endorsed by WHO, UNAIDS, and UNODC ( 2008) . In addition to these nine interventions, establishing drug and alcohol rehabilitation centers and building a supportive environ ment for support groups as well as 12 step and livelihood pro grams are essential for the long term stability of drug using populations. Some of these interventions (such as HTC; provision of ART for those who are HIV infected; treatment of sexually transmitted infections; condom distribution programs for people who use drugs and their sexual partners; and targeted HIV prevention and treatment IEC for people who inject drugs and their sexual partners) are available in several African countries. However, for the most part, as the HIV epidemic remains a generalized epidemic, these prevention and treatment services tend to target the general population rather than people who use drugs specifically (Myers 2012) . Due to high levels of stigma, people who use drugs may not feel and may not be wel comed by these generic health services, and this may impact on the degree to which these services are utilized. One strategy for addressing this gap in African countries with limited resources would be to consider expanding existing HIV prevention and treatment services for other most at risk populations (MARPs) to include services for people who use drugs (Myers 2012) . Surveys of MARPs in Africa have consistently found overlaps between various MARPs including men who have sex with men, sex workers, and people who use drugs (Johnston, Holman, Dahoma, Miller, Kim, Mussa, et al. 2010; Parry, Peter sen, Carney, Dewing & Needle 2008) . Often organizations serving these MARPs are located in highly accessible areas and already provide preventative health services (typically related to sexual health or blood borne virus testing) to their clients. Given that some of their clientele will be using drugs, they may be willing to expand their target population to include people who use drugs specifically and adapt their services to meet the intervention needs of people who use drugs (Myers 2012) . In con texts where resources for harm reduction services are limited, this may be an efficient and acceptable way of providing targeted ser vices for people who use drugs.
In contrast, other core HIV prevention services for people who use drugs are largely unavailable in the African context. Specifi cally, needle and syringe exchange programs and MAT remain difficult to access for the large majority of people who use opiates despite overwhelming evidence from multiple systematic reviews that these services reduce HIV transmission and improve quality of life for people who inject drugs (Cross, Saun ders & Bartelli 1998; Gowing, Farrell, Bornemann, Sullivan & Ali 2008; Tilson, Aramrattana & Bozzette 2007) . In some African countries, laws that prohibit the distribution of syringes still exist, which prevents NSPs from moving beyond the pilot phase. Similarly, policy makers' apathy toward drug users and their failure to grasp how investing in NSPs and effective treat ment for opiate dependence will benefit not only drug users but also the general public through reducing risks of HIV trans mission hamper the provision of these services. To move beyond this stalemate, a strong advocacy and drug user network that will continue to argue for greater access to effective medi cations for opiate dependence is needed in Africa. Outreach ser vices can also be initiated through community based organizations utilizing traditional outreach workers (i.e. non drug using social workers or health professionals or para pro fessionals), storefront drop in centers, providing IEC for HIV risk reduction, needle and syringe exchange, needle and syringe cleaning kits, 12 step programs, counseling services for individuals, families, and groups, mobile units offering HTC and comprehensive medical services offered through the Ministry of Health facilities including MAT, and referrals to HIV care and treatment; TB diagnosis, care, and treatment; hepatitis C virus diagnosis, care, and treatment; diagnosis and treatment for STIs and other co morbidities, etc.
Way forward
We have reached a pivotal point in addressing drug related issues in Africa. As has been discussed, drug trafficking and use have dramatically increased in regions of sub Saharan Africa, which also face a high burden of HIV. Governments, international agencies, and program implementers must rise to the occasion and address these intersecting issues as they not only have a dele terious impact on the health and well being of people who use drugs, but also negatively impact on efforts to curtail the general ized HIV epidemics present in many countries in this region.
